RegCell, a biotech company, revealed that it has officially appointed Michael McCullar as CEO and representative director. Previously, he served as CEO of OnQuality Pharmaceuticals, where he provided executive leadership to this targeted oncology supportive therapy company focused on developing pioneering medications tailored to address the intricacies of cancer treatment-related toxicities.
